(Q44124964)

30 November 2017

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease (English)

1 reference

30 November 2017

0 references

0 references

2

1 reference

30 November 2017

Lisa C Silbert

4

0 references

Jeffrey Kaye

object named as

Jeffrey A Kaye

9

0 references

Dejan Milatovic

3

object named as

Dejan Milatovic

1 reference

30 November 2017

1

Thomas J Montine

1 reference

30 November 2017

Theresa Dang

5

1 reference

30 November 2017

Stephanie Sanchez

6

1 reference

30 November 2017

Erin Terry

7

1 reference

30 November 2017

L Jackson Roberts

8

1 reference

30 November 2017

Jason D Morrow

10

1 reference

30 November 2017

language of work or name

1 reference

1 August 2002

1 reference

30 November 2017

1 reference

30 November 2017

52

1 reference

30 November 2017

175-179

1 reference

30 November 2017

2

1 reference

Increased CSF F2-isoprostane concentration in probable AD.

30 November 2017

1 reference

Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease

21 January 2018

1 reference

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.

21 January 2018

1 reference

The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients

21 January 2018

1 reference

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

21 January 2018

1 reference

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

21 January 2018

1 reference

Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus

21 January 2018

1 reference

Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay

21 January 2018

1 reference

Enhanced hippocampal F2-isoprostane formation following kainate-induced seizures

21 January 2018

1 reference

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.10272

1 reference

30 November 2017

1 reference